Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.14 EUR | -1.61% | +1.22% | +3.76% |
01-10 | DELIVERY HERO : Buy rating from UBS | ZD |
01-09 | Delivery Hero in demand – Morgan Stanley positive for industry | DP |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1.24B | 2.47B | 5.86B | 8.58B | 9.94B | |||||
Total Revenues | 1.24B | 2.47B | 5.86B | 8.58B | 9.94B | |||||
Cost of Goods Sold, Total | 926M | 1.98B | 4.6B | 6.35B | 6.97B | |||||
Gross Profit | 311M | 494M | 1.26B | 2.23B | 2.97B | |||||
Selling General & Admin Expenses, Total | 950M | 1.38B | 2.65B | 3.6B | 3.55B | |||||
Provision for Bad Debts | 8.8M | 19.7M | 35.4M | 38.9M | 30.9M | |||||
Other Operating Expenses | -8M | -6.4M | 45.8M | 12.9M | 56M | |||||
Other Operating Expenses, Total | 951M | 1.4B | 2.73B | 3.65B | 3.64B | |||||
Operating Income | -640M | -903M | -1.47B | -1.42B | -664M | |||||
Interest Expense, Total | -14.4M | -65.4M | -127M | -224M | -359M | |||||
Interest And Investment Income | 7.6M | 3.7M | 7.3M | 45.3M | 127M | |||||
Net Interest Expenses | -6.8M | -61.7M | -120M | -179M | -232M | |||||
Income (Loss) On Equity Invest. | -99.7M | -86.7M | -179M | -121M | -7.4M | |||||
Currency Exchange Gains (Loss) | -4.8M | -161M | 82M | -50.1M | -144M | |||||
Other Non Operating Income (Expenses) | 59.2M | -144M | 317M | -150M | -114M | |||||
EBT, Excl. Unusual Items | -692M | -1.36B | -1.37B | -1.92B | -1.16B | |||||
Merger & Related Restructuring Charges | - | - | -181M | -30M | - | |||||
Impairment of Goodwill | -1.9M | - | -85.9M | -742M | -858M | |||||
Gain (Loss) On Sale Of Investments | 25.4M | -22.2M | 21.8M | -14M | -1M | |||||
Gain (Loss) On Sale Of Assets | -2.2M | 6.6M | 648M | -65M | -1.4M | |||||
Asset Writedown | - | - | - | - | -140M | |||||
Other Unusual Items | 7.2M | -16.3M | 8.6M | -65.4M | -1M | |||||
EBT, Incl. Unusual Items | -663M | -1.39B | -958M | -2.83B | -2.16B | |||||
Income Tax Expense | 26.5M | 14.2M | 138M | 141M | 142M | |||||
Earnings From Continuing Operations | -690M | -1.4B | -1.1B | -2.98B | -2.3B | |||||
Earnings Of Discontinued Operations | 920M | - | - | - | - | |||||
Net Income to Company | 230M | -1.4B | -1.1B | -2.98B | -2.3B | |||||
Minority Interest | 1.1M | -1.9M | -3.6M | -14.9M | 7.2M | |||||
Net Income - (IS) | 231M | -1.4B | -1.1B | -2.99B | -2.3B | |||||
Net Income to Common Incl Extra Items | 231M | -1.4B | -1.1B | -2.99B | -2.3B | |||||
Net Income to Common Excl. Extra Items | -689M | -1.4B | -1.1B | -2.99B | -2.3B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 1.22 | -7 | -4.47 | -11.21 | -8.57 | |||||
Basic EPS - Continuing Operations | -3.62 | -7 | -4.47 | -11.21 | -8.57 | |||||
Basic Weighted Average Shares Outstanding | 190M | 201M | 246M | 267M | 268M | |||||
Net EPS - Diluted | 1.22 | -7 | -4.47 | -11.21 | -8.57 | |||||
Diluted EPS - Continuing Operations | -3.62 | -7 | -4.47 | -11.21 | -8.57 | |||||
Diluted Weighted Average Shares Outstanding | 190M | 201M | 246M | 267M | 268M | |||||
Normalized Basic EPS | -2.27 | -4.24 | -3.5 | -4.55 | -2.68 | |||||
Normalized Diluted EPS | -2.27 | -4.24 | -3.5 | -4.55 | -2.68 | |||||
Payout Ratio | - | - | - | - | -0.14 | |||||
American Depositary Receipts Ratio (ADR) | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |||||
Supplemental Items | ||||||||||
EBITDA | -585M | -808M | -1.25B | -1.13B | -407M | |||||
EBITA | -611M | -877M | -1.36B | -1.29B | -502M | |||||
EBIT | -640M | -903M | -1.47B | -1.42B | -664M | |||||
EBITDAR | -578M | -800M | -1.23B | -1.12B | -383M | |||||
Effective Tax Rate - (Ratio) | -3.99 | -1.02 | -14.42 | -4.98 | -6.57 | |||||
Total Current Taxes | 31.4M | 56.9M | 153M | 169M | 281M | |||||
Total Deferred Taxes | -4.9M | -42.7M | -14.9M | -27.8M | -139M | |||||
Normalized Net Income | -431M | -850M | -860M | -1.21B | -718M | |||||
Interest on Long-Term Debt | 5.3M | 60.1M | 110M | 22.3M | 22.8M | |||||
Supplemental Operating Expense Items | ||||||||||
Marketing Expenses | 495M | 632M | 1.3B | 1.47B | 1.46B | |||||
Selling and Marketing Expenses | 495M | 632M | 1.3B | 1.47B | 1.46B | |||||
General and Administrative Expenses | 448M | 742M | 1.33B | 2.12B | 2.08B | |||||
Research And Development Expense From Footnotes | 65M | 129M | 277M | 456M | 480M | |||||
Net Rental Expense, Total | 6.6M | 8.7M | 15.7M | 15M | 24.1M | |||||
Imputed Operating Lease Interest Expense | 12.48M | 2.79M | 4.18M | 5.28M | 12.22M | |||||
Imputed Operating Lease Depreciation | -5.88M | 5.91M | 11.52M | 9.72M | 11.88M | |||||
Stock-Based Comp., G&A Exp. (Total) | 44.8M | 86.1M | 303M | 326M | 247M | |||||
Total Stock-Based Compensation | 44.8M | 86.1M | 303M | 326M | 247M |